EPO and perinatal asphyxia: Multiple clinical trials have demonstrated the safety and efficacy of erythropoietin in improving neurodevelopmental outcomes in infants with HIE.[8–10] A recent review involving randomized and non-randomized trials assessed neurodevelopmental disorders in infants with HIE.